Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liquidation
Biotech
Hookipa, having sold off vaccines to Gilead, opts to wind down
With its Poolbeg merger plans having bitten the dust and key assets sold to Gilead, Hookipa Pharma has decided it’s time to shut up shop completely.
James Waldron
Jul 21, 2025 3:15am
Alis wants to free capital 'trapped' at struggling biotechs
Apr 18, 2025 9:45am
Struggling Relmada pays $3M for Tourette's asset from Asarina
Feb 7, 2025 11:00am
Asarina to close after efforts to partner Tourette's drug fail
Jul 24, 2024 10:32am
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
Mar 1, 2024 10:20am
The unraveling of EQRx's low-cost drug dream
Oct 5, 2023 10:47am